Alcon (ALC) Income from Non-Controlling Interests (2019 - 2023)
Alcon (ALC) posted Income from Non-Controlling Interests of -$159.0 million for Q4 2023, down 4.61% on a QoQ basis from -$152.0 million in Q4 2022, and down 4.61% year-over-year from -$166.7 million in Q4 2022.
Analysis
Alcon (ALC) Income from Non-Controlling Interests (2019 - 2023) Analysis & Trends
Alcon has reported Income from Non-Controlling Interests for 5 years, with the latest figure at -$159.0 million in Q4 2023.
- On a quarterly basis, Income from Non-Controlling Interests fell 4.61% year-over-year to -$159.0 million in Q4 2023; TTM through Jun 2026 was -$159.0 million, a 48.87% increase from a year earlier, with the FY2022 full-year figure at -$152.0 million, down 0.66% from the prior year.
- Income from Non-Controlling Interests was -$159.0 million for Q4 2023 at Alcon, down from -$152.0 million in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was -$113.0 million in Q4 2020, with the low at -$159.0 million in Q4 2023.
- Average Income from Non-Controlling Interests over 5 years is -$137.8 million, with a median of -$151.0 million recorded in 2021.
- The sharpest annual moves came in 2020 and 2021: Income from Non-Controlling Interests gained 0.88% in 2020, then tumbled 33.63% in 2021.
- Over 5 years, Income from Non-Controlling Interests stood at -$114.0 million in 2019, then increased by 0.88% to -$113.0 million in 2020, then tumbled by 33.63% to -$151.0 million in 2021, then fell by 0.66% to -$152.0 million in 2022, then decreased by 4.61% to -$159.0 million in 2023.
- The last three Income from Non-Controlling Interests figures came in at -$159.0 million (Q4 2023), -$152.0 million (Q4 2022), and -$151.0 million (Q4 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 6.60 Mn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 9.00 Mn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | -2.00 Mn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | -500,000.00 |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | - |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 900,000.00 |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | 1.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -159.00 Mn |
| Dec 31, 2022 | -152.00 Mn |
| Dec 31, 2021 | -151.00 Mn |
| Dec 31, 2020 | -113.00 Mn |
| Dec 31, 2019 | -114.00 Mn |